证券记录 · 已归档季度
PODD
Insulet Corp. · Healthcare · Medical - Devices
24被追踪持有人
+1Δ持有人
35.22M持有股份
$10.87B报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +4.3% ·
股份流向 -1.5% ·
净新建仓位 0.0%
· 公式
持有人分散化：持有人数增多，合计持仓比例缩小。
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | -1 | 427.34K | $55.53M | n/a | −1 |
| Q2 2026 | 158 | 0 | 52.88M | $8.06B | +7 | −8 |
| Q1 2026 | 162 | -3 | 53.76M | $11.28B | +2 | −6 |
| Q4 2025 | 164 | +1 | 61.46M | $17.44B | +2 | n/a |
| Q3 2025 | 24 | +1 | 35.22M | $10.87B | +1 | −1 |
| Q2 2025 | 21 | -2 | 34.19M | $10.74B | n/a | −2 |
| Q1 2025 | 20 | +1 | 10.99M | $2.88B | +1 | n/a |
| Q4 2024 | 19 | 0 | 11.49M | $3.00B | +1 | −1 |
| Q3 2024 | 18 | 0 | 8.60M | $2.00B | +1 | −1 |
| Q2 2024 | 18 | n/a | 10.07M | $2.03B | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 8.80M | +1.0% | $2.72B | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 2 | Fidelity (FMR) ✦ | 7.57M | +0.8% | $2.34B | 0.1% | ▲ Add | 2 | SEC ↗ ×6 |
| 3 | BlackRock ✦ (被动) | 6.59M | +2.8% | $2.04B | 0.0% | ▲ Add | 2 | SEC ↗ ×21 |
| 4 | State Street Global Advisors ✦ (被动) | 3.09M | +1.1% | $954.03M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Baillie Gifford ✦ | 2.09M | -2.0% | $645.77M | 0.5% | ▼ Trim | 6 | SEC ↗ ×4 |
| 6 | Geode Capital Management ✦ (被动) | 1.97M | +2.0% | $604.49M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Morgan Stanley ✦ | 1.27M | n/a | $391.81M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 8 | Goldman Sachs Group ✦ | 757.81K | n/a | $233.96M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 9 | JPMorgan Chase ✦ | 556.53K | n/a | $171.82M | 0.0% | n/c | 1 | SEC ↗ ×34 |
| 10 | Renaissance Technologies ✦ | 390.89K | +4.5% | $120.68M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 352.44K | -54.3% | $108.81M | 0.1% | ▼ Trim | 6 | SEC ↗ ×2 |
| 12 | Marshall Wace ✦ | 280.47K | -55.4% | $86.59M | 0.1% | ▼ Trim | 6 | SEC ↗ ×3 |
| 13 | Two Sigma Investments ✦ | 250.80K | -31.0% | $77.43M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 235.60K | +5.2% | $72.74M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 15 | Millennium Management ✦ | 200.87K | -14.4% | $62.01M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 16 | Wellington Management ✦ | 189.52K | -33.0% | $58.51M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 17 | AQR Capital Management ✦ | 175.47K | +63.1% | $53.92M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 18 | Capital World Investors ✦ | 168.00K | 0.0% | $51.87M | 0.0% | Held | 6 | SEC ↗ |
| 19 | PRIMECAP Management ✦ | 124.11K | -34.2% | $38.32M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 20 | Arrowstreet Capital ✦ | 66.37K | +147.9% | $20.49M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | Fisher Asset Management ✦ | 46.27K | +38.0% | $14.29M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 22 | Bridgewater Associates ✦ | 21.09K | +816.7% | $6.51M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 23 | Gotham Asset Management ✦ | 15.64K | +195.8% | $4.83M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 24 | Adage Capital Partners ✦ | 14.10K | 新增 | $4.35M | 0.0% | New | 1 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Adage Capital Partners | $4.35M | 0.0% |
已清仓
| Norges Bank | $324.69M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 779 持有人, 69.27M 股份, $13.82B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
Aug 21
McEvoy Ashley
Officer, Director · President and CEO · 1.10K 股 @ 147.47 · $162,217
公开市场卖出 (S)
在我们的覆盖窗口内无内部人士公开市场卖出记录。
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 06
SC 13G/A: FMR LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据